The Claim

8-prenylnaringenin (8-PN) prevents bone loss in ovariectomized rats, an animal model simulating hormone-dependent osteoporosis in postmenopausal women.

Source: Tissue specificity of 8-prenylnaringenin: protection from ovariectomy induced bone loss with minimal trophic effects on the uterus.

What the research says

Roughly balanced

Support and challenge are close. The picture may shift as more studies come in.

Supports
6score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Cause and effect
1 study reviewed
In plain English

A compound called 8-prenylnaringenin (8-PN) was found to fully stop bone loss in rats that had their ovaries removed - these rats are used to study a condition similar to osteoporosis that happens to women after menopause.

See the scientific wording

8-prenylnaringenin (8-PN) completely protects against bone loss in ovariectomized rats, an established animal model for hormone-dependent osteoporosis in postmenopausal women

What the research says

1 study

  1. Study: Tissue specificity of 8-prenylnaringenin: protection from ovariectomy induced bone loss with minimal trophic effects on the uterus.

    The study tested the same compound (8-PN) in the same type of animals (ovariectomized rats) and found it completely protected against bone loss, exactly as the claim states.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.